06/09/2026
Depression can be challenging, especially when traditional antidepressants haven’t provided enough relief.
Spravato® (esketamine) is an FDA-approved treatment option used in conjunction with an oral antidepressant for certain adults with treatment-resistant depression (TRD). Treatment is administered under medical supervision in a safe clinical setting.
At Avant Interventional Psychiatry, our team works closely with each patient to determine the most appropriate treatment options based on their individual needs and goals.
💚 FDA-approved treatment option for eligible adults with TRD
💚 Administered under medical supervision
💚 Personalized treatment plans
💚 Available at all Avant locations
Interested in learning more? Contact our office to schedule a consultation and find out whether Spravato® may be right for you.